Survival after allogeneic bone marrow transplantation (BMT) in patients randomised into a trial of IFN-alpha versus chemotherapy: No significant adverse effect of prolonged IFN-alpha administration.
Príomhchruthaitheoirí: | , , |
---|---|
Formáid: | Journal article |
Foilsithe / Cruthaithe: |
1995
|